Thomas Kühr

771 total citations
37 papers, 510 citations indexed

About

Thomas Kühr is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Thomas Kühr has authored 37 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 11 papers in Oncology and 10 papers in Genetics. Recurrent topics in Thomas Kühr's work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Gastric Cancer Management and Outcomes (5 papers). Thomas Kühr is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Gastric Cancer Management and Outcomes (5 papers). Thomas Kühr collaborates with scholars based in Austria, Germany and United Kingdom. Thomas Kühr's co-authors include Josef Thaler, Oliver Bechter, Wolfgang Hilbe, Georg Pall, Wolfgang Eisterer, Sonja Burgstaller, Margit Dlaska, Ewald Wöll, J. Thaler and Francis Grand and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Thomas Kühr

36 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kühr Austria 12 150 136 132 128 101 37 510
Kishiko Nakamura Japan 13 118 0.8× 123 0.9× 74 0.6× 43 0.3× 107 1.1× 18 440
Chantal Brouzes France 12 63 0.4× 165 1.2× 53 0.4× 115 0.9× 77 0.8× 23 397
Kun Ru China 13 184 1.2× 206 1.5× 39 0.3× 144 1.1× 59 0.6× 52 483
Takuya Komeno Japan 13 144 1.0× 278 2.0× 43 0.3× 166 1.3× 175 1.7× 49 595
Nozomi Iwanaga Japan 12 158 1.1× 67 0.5× 128 1.0× 37 0.3× 181 1.8× 47 611
Emmanouil Spanoudakis Greece 13 125 0.8× 166 1.2× 45 0.3× 101 0.8× 258 2.6× 49 599
Amal Al-Seraihy Saudi Arabia 15 120 0.8× 275 2.0× 68 0.5× 79 0.6× 132 1.3× 47 559
Toshio Kakihara Japan 12 164 1.1× 60 0.4× 60 0.5× 40 0.3× 48 0.5× 47 410
W Kaulfersch Austria 11 105 0.7× 149 1.1× 44 0.3× 30 0.2× 234 2.3× 29 526
Kumiko Shimoyama Japan 11 56 0.4× 62 0.5× 91 0.7× 43 0.3× 70 0.7× 30 342

Countries citing papers authored by Thomas Kühr

Since Specialization
Citations

This map shows the geographic impact of Thomas Kühr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kühr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kühr more than expected).

Fields of papers citing papers by Thomas Kühr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kühr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kühr. The network helps show where Thomas Kühr may publish in the future.

Co-authorship network of co-authors of Thomas Kühr

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kühr. A scholar is included among the top collaborators of Thomas Kühr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kühr. Thomas Kühr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Terpos, Evangelos, Borhane Slama, Renato Zambello, et al.. (2020). Real-World Evidence of the Use of Carfilzomib Among Multiple Myeloma Patients with at Least One Prior Therapy across 10 European Countries and Israel. Blood. 136(Supplement 1). 38–39. 4 indexed citations
3.
Steger, Guenther G., Edgar Petru, Ferdinand Haslbauer, et al.. (2016). Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study. Annals of Oncology. 27. vi74–vi74. 2 indexed citations
4.
Bareck, Evelyne, Ahmed Ba‐Ssalamah, Thomas Brodowicz, et al.. (2013). Gastrointestinal stromal tumors: Diagnosis, therapy and follow-up care in Austria. Wiener Medizinische Wochenschrift. 163(5-6). 137–152. 10 indexed citations
5.
Burgstaller, Sonja, Michael Fridrik, Thomas Kühr, et al.. (2013). Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis. Wiener klinische Wochenschrift. 125(7-8). 196–199. 4 indexed citations
6.
Ploner, F., Wolfgang Lamm, Wolfgang Eisterer, et al.. (2013). The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS). Journal of Cancer Research and Clinical Oncology. 139(8). 1337–1342. 9 indexed citations
7.
Ploner, Ferdinand, Johannes Zacherl, Friedrich Wrba, et al.. (2009). Gastrointestinal stromal tumors: Recommendations on diagnosis, therapy and follow-up care in Austria. Wiener klinische Wochenschrift. 121(23-24). 780–790. 1 indexed citations
8.
Burgstaller, Sonja, et al.. (2009). Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. European Journal of Cancer Care. 19(5). 676–681. 50 indexed citations
9.
Thaler, J., Thomas Kühr, Günther Gastl, et al.. (2008). Rekombinantes Interferon α-2c bei Ph-positiver chronischer myeloischer Leukämie: Ergebnisse einer multizentrischen Phase-II-Studie. DMW - Deutsche Medizinische Wochenschrift. 116(19). 721–728.
10.
Kühr, Thomas, Wolfgang Eisterer, K. Gattringer, et al.. (2006). Oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. Final results of a multicenter phase II trial. Journal of Clinical Oncology. 24(18_suppl). 4070–4070. 2 indexed citations
11.
Bechter, Oliver, Wolfgang Eisterer, Margit Dlaska, Thomas Kühr, & Josef Thaler. (2002). CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. Experimental Hematology. 30(1). 26–33. 58 indexed citations
12.
Hilbe, Wolfgang, Thomas Kühr, Ute Apfelbeck, et al.. (2001). Dose Escalation of Ara-C May Improve Response Rates in a Subgroup of Chronic Myeloid Leukemia Patients with Poor Response to Interferon-α and Low-dose Ara-C. Leukemia & lymphoma. 42(6). 1283–1288. 1 indexed citations
13.
Hilbe, Wolfgang, Thomas Kühr, Ute Apfelbeck, et al.. (2001). Dose Escalation of Ara-C May Improve Response Rates in a Subgroup of Chronic Myeloid Leukemia Patients with Poor Response to Interferon-α and Low-dose Ara-C. Leukemia & lymphoma. 42(6). 1283–1288. 1 indexed citations
14.
Lhotta, Karl, Thomas Kühr, Hans J. Rumpelt, et al.. (1999). Thrombotic Microangiopathy with Renal Failure in Two Patients Undergoing Gemcitabine Chemotherapy. American Journal of Nephrology. 19(5). 590–593. 29 indexed citations
15.
Kühr, Thomas, Oliver Bechter, Stephan Geley, et al.. (1999). Detection and quantitation of genetically marked acute myeloid leukemia by competitive polymerase chain reaction after autologous bone marrow transplantation. Experimental Hematology. 27(2). 266–271. 3 indexed citations
16.
Bechter, Oliver, Wolfgang Eisterer, S Dirnhofer, et al.. (1999). Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL). Leukemia Research. 23(5). 483–488. 12 indexed citations
17.
Thaler, J., Guenther Gastl, Dietger Niederwieser, et al.. (1996). Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Annals of Hematology. 72(6). 349–355. 11 indexed citations
18.
Kühr, Thomas, Karel Hála, Hermann Dietrich, Manfred Herold, & Georg Wick. (1994). Genetically Determined Target Organ Susceptibility in the Pathogenesis of Spontaneous Autoimmune Thyroiditis: Aberrant Expression of MHC-Class II Antigens and the Possible Role of Virus. Journal of Autoimmunity. 7(1). 13–25. 12 indexed citations
19.
Wick, Georg, et al.. (1992). The Role of Modulatory Factors in the Multifacetted Pathogenesis of Autoimmune Thyroiditis. International Reviews of Immunology. 9(2). 77–89. 7 indexed citations
20.
Wick, Georg, G Krömer, Nikolaus Neu, et al.. (1987). The multi-factorial pathogenesis of autoimmune disease. Immunology Letters. 16(3-4). 249–257. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kishiko Nakamura Breakdown of academic impact, for papers by Chantal Brouzes Breakdown of academic impact, for papers by Kun Ru Breakdown of academic impact, for papers by Takuya Komeno Breakdown of academic impact, for papers by Nozomi Iwanaga Breakdown of academic impact, for papers by Emmanouil Spanoudakis Breakdown of academic impact, for papers by Amal Al-Seraihy Breakdown of academic impact, for papers by Toshio Kakihara Breakdown of academic impact, for papers by W Kaulfersch Breakdown of academic impact, for papers by Kumiko Shimoyama
Rankless by CCL
2026